(Q43641509)

25 November 2017

title

Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues (English)

1 reference

25 November 2017

Kim DK

1

1 reference

25 November 2017

Lee N

2

1 reference

25 November 2017

Lee JY

3

1 reference

25 November 2017

Ryu DH

4

1 reference

25 November 2017

Kim JS

5

1 reference

25 November 2017

Lee SH

6

1 reference

25 November 2017

Choi JY

7

1 reference

25 November 2017

Chang K

8

1 reference

25 November 2017

Kim YW

9

1 reference

25 November 2017

Im GJ

10

1 reference

25 November 2017

Choi WS

11

1 reference

25 November 2017

Kim TK

12

1 reference

25 November 2017

Ryu JH

13

1 reference

25 November 2017

Kim NH

14

1 reference

25 November 2017

Lee K

15

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Bioorganic & Medicinal Chemistry

25 November 2017

published in

1 reference

25 November 2017

volume

9

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1609-1616

1 reference

Physiology of penile erection

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

The role of phosphodiesterase inhibitors in impotence.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Drugs for the treatment of impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Phosphodiesterase inhibitors in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900055-4

7 January 2021

10.1016/S0968-0896(01)00055-4

Identifiers

DOI

1 reference

25 November 2017

1 reference